This guideline replaces the ‘Note for guidance on clinical investigation of medicinal products in the treatment of lipid disorders (CPMP/EWP/3020/03)’. Rev. 1 and Rev. 2 were combined: Rev. 1 was regarding imaging surrogate endpoints Rev. 2 was regarding the need for outcome studies based on safety data at the time of Marketing Authorisation Application.

Primary bovine muscle cell culture studies were conducted to determine whether implanting heifers had a direct effect on in vitro protein synthesis and degradation and to determine the effect of implanting heifers on longissimus muscle palatability. Feedlot heifers (n = 96) were administered one of six implant regimens to characterize their effect on in vitro amino acid uptake and protein degra...

Brucellosis, caused by the genus Brucella bacterium, is a well-known infection among domestic animals. Considering the serious economic and medical consequences of this infection, various preventive efforts have been made through using recombinant vaccines, based on outer membrane protein (OMP) antigens of Brucella species. The objective of the present study was to clone, analyze the sequence, ...

101 Recording of Absences (Attendance) [1] [rev. Oct 1999] 102 Hours of Work [2] [rev. Oct 1999] 103 Vacation Leave [3] [rev. Aug 2004] 104 Sick Leave [4] [rev. Nov 1999] 105 Membership Fees [5] [rev. Oct 1999] 106 Termination [6] [rev. Oct 1999] 107 Acting Pay [7] [rev. Nov 1999] 108 Professional Development Reimbursement [8] [rev. Jul 2005] 109 Self-Funded Leave, see Policy 501Leave of Absenc...

101 Recording of Absences (Attendance) [1] [rev. Oct 1999] 102 Hours of Work [2] [rev. Oct 1999] 103 Vacation Leave [3] [rev. Aug 2004] 104 Sick Leave [4] [rev. Nov 1999] 105 Membership Fees [5] [rev. Oct 1999] 106 Termination [6] [rev. Oct 1999] 107 Acting Pay [7] [rev. Nov 1999] 108 Professional Development Reimbursement [8] [rev. Jul 2005] 109 Self-Funded Leave, see Policy 501Leave of Absenc...

101 Recording of Absences (Attendance) [1] [rev. Oct 1999] 102 Hours of Work [2] [rev. Oct 1999] 103 Vacation Leave [3] [rev. Aug 2004] 104 Sick Leave [4] [rev. Nov 1999] 105 Membership Fees [5] [rev. Oct 1999] 106 Termination [6] [rev. Oct 1999] 107 Acting Pay [7] [rev. Nov 1999] 108 Professional Development Reimbursement [8] [rev. Jul 2005] 109 Self-Funded Leave, see Policy 501Leave of Absenc...

0

101 Recording of Absences (Attendance) [1] [rev. Oct 1999] 102 Hours of Work [2] [rev. Oct 1999] 103 Vacation Leave [3] [rev. Aug 2004] 104 Sick Leave [4] [rev. Nov 1999] 105 Membership Fees [5] [rev. Oct 1999] 106 Termination [6] [rev. Oct 1999] 107 Acting Pay [7] [rev. Nov 1999] 108 Professional Development Reimbursement [8] [rev. Jul 2005] 109 Self-Funded Leave, see Policy 501Leave of Absenc...

101 Recording of Absences (Attendance) [1] [rev. Oct 1999] 102 Hours of Work [2] [rev. Oct 1999] 103 Vacation Leave [3] [rev. Aug 2004] 104 Sick Leave [4] [rev. Nov 1999] 105 Membership Fees [5] [rev. Oct 1999] 106 Termination [6] [rev. Oct 1999] 107 Acting Pay [7] [rev. Nov 1999] 108 Professional Development Reimbursement [8] [rev. Jul 2005] 109 Self-Funded Leave, see Policy 501Leave of Absenc...